Muc4/MUC4 functions and regulation in cancer

Future Oncology

Volumn 5, Issue 10, 2009, Pages 1631-1640

  Carraway, Kermit L ^a   Theodoropoulos, George ^a   Kozloski, Goldi A ^a   Carothers Carraway, Coralie A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Apoptosis; ErbB2 RrbB3 regulation; Ligand; Membrane mucin; Metastasis; MUC4; Post translational regulation; Proteosomal degradation; Transcription

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; JANUS KINASE; MUCIN 4; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B; SMAD7 PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL ADHESION; CELL AGGREGATION; EPIGENETICS; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR LOCALIZATION;

ANIMALS; HUMANS; MUCIN-4; NEOPLASMS; RATS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 75149137086     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.125     Document Type: Review

References (86)

1. Sherblom AP, Buck RL, Carraway KL: Purification of the major sialoglycoproteins of 13762 MAT-B1 and MAT-C1 rat ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride. J. Biol. Chem. 255, 783-790 (1980)
2. Sherblom AP, Carraway KL: A complex of two cell surface glycoproteins from ascites mammary adenocarcinoma cells. J. Biol. Chem. 255, 12051-12059 (1980). ■ First isolation and characterization of rat Muc4, then called sialomucin complex.
3. Porchet N, Nguyen VC, Dufosse J et al.: Molecular cloning and chromosomal localization of a novel human tracheobronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun. 175, 414-422 (1991). ■■ First partial clone of human MUC4 and designation as member of the mucin 'family'.
4. Sheng Z, Wu K, Carraway KL, Fregien N: Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex. A new member of the epidermal growth factor superfamily. J. Biol. Chem. 267, 16341-16346 (1992).
5. Wu K, Fregien N, Carraway KL: Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell surface glycoprotein complex of ascites rat mammary adenocarcinoma cells. J. Biol. Chem. 269, 11950-11955 (1994).
6. Moniaux N, Nollet S, Porchet N, Degand P, Laine A, Aubert JP: Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J. 338, 325-333 (1999).
7. Hull SR, Laine RA, Kaizu T, Rodriguez I, Carraway KL: Structures of the O-linked oligosaccharides of the major cell surface sialoglycoprotein of MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma. J. Biol. Chem. 259, 4866-4877 (1984).
8. Hull SR, Sheng Z, Vanderpuye O, David C, Carraway KL: Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Biochem J. 265, 121-129 (1990).
9. Sheng ZQ, Hull SR, Carraway KL: Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J. Biol. Chem. 265, 8505-8510 (1990).
10. Komatsu M, Arango ME, Carraway KL: Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis. Biochem J. 368, 41-48 (2002).
11. Escande F, Lemaitre L, Moniaux N, Batra SK, Aubert JP, Buisine MP: Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants. Eur. J. Biochem. 269, 3637-3644 (2002).
12. Singh AP, Chaturvedi P, Batra SK: Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res. 67, 433-436 (2007).
13. Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK: Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 64, 622-630 (2004).
14. Komatsu M, Tatum L, Altman NH, Carothers Carraway CA, Carraway KL: Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional antiadhesive glycoprotein. Int. J. Cancer 87, 480-486 (2000). ■ Role of Muc4 in promoting metastasis of tumor cells.
15. Weed DT, Gomez-Fernandez C, Yasin M et al.: MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes. Laryngoscope 114(Suppl.), 1-32 (2004).
16. Komatsu M, Carraway CA, Fregien NL, Carraway KL: Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J. Biol. Chem. 272, 33245-33254 (1997). ■ Effect of Muc4 as anti-adhesive in preventing cellular interactions.
17. Carraway KL, Perez A, Idris N et al.: Muc4/ sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog. Nucleic Acid Res. Mol. Biol. 71, 149-185 (2002).
18. Komatsu M, Yee L, Carraway KL: Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res. 59, 2229-2236 (1999).
19. Price-Schiavi SA, Jepson S, Li P et al.: Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Int. J. Cancer 99, 783-791 (2002).
20. Nagy P, Friedländer E, Tanner M et al.: Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res. 65, 473-482 (2005).
21. Clynes RA, Towers TL, Presta LG, Ravetch JV: Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6, 443-446 (2000).
22. McNeer RR, Huang D, Fregien NL, Carraway KL: Sialomucin complex in the rat respiratory tract: a model for its role in epithelial protection. Biochem J. 330, 737-744 (1998).
23. Pino V, Ramsauer VP, Salas P, Carothers Carraway CA, Carraway KL: Membrane mucin Muc4 induces density-dependent changes in ERK activation in mammary epithelial and tumor cells: role in reversal of contact inhibition. J. Biol. Chem. 281, 29411-29420 (2006).
24. Hattrup CL, Gendler SJ: Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431-457 (2008).
25. Carraway KL 3rd, Rossi EA, Komatsu M et al.: An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol. Chem. 274, 5263-5266 (1999). ■■ Report of Muc4 interaction with ErbB2 and modulation of its signaling.
26. Jepson S, Komatsu M, Haq B et al.: Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 21, 7524-7532 (2002).
27. Ramsauer VP, Pino V, Farooq A, Carothers Carraway CA, Salas PJ, Carraway KL: Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. Mol. Biol. Cell 17, 2931-2941 (2006).
28. Ramsauer VP, Carraway CA, Salas PJ, Carraway KL: Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J. Biol. Chem. 278, 30142-30147 (2003). ■ Role of Muc4 in localization of ErbB2 in polarized epithelial cells.
29. Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137 (2001).
30. Lemmon MA: Ligand-induced ErbB receptor dimerization. Exp. Cell Res. 315, 638-648 (2009).
31. Garrett TP, McKern NM, Lou M et al.: The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol. Cell 11, 495-505 (2003).
32. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL 3rd: Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA 91, 8132-8136 (1994).
33. Carraway KL 3rd, Cantley LC: A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78, 5-8 (1994).
34. Houde M, Laprise P, Jean D, Blais M, Asselin C, Rivard N: Intestinal epithelial cell differentiation involves activation of p38 mitogen activated protein kinase that regulates the homeobox transcription factor CDX2. J. Biol. Chem. 276, 21885-21894 (2001).
35. Vermeer PD, Einwalter LA, Moninger TO et al.: Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 422, 322-326 (2003).
36. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS: ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3, 785-792 (2001).
37. Funes M, Miller JK, Lai C, Carraway KL 3rd, Sweeney C: The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. J. Biol. Chem. 281, 19310-19319 (2006).
38. Chaturvedi P, Singh AP, Batra SK: Structure, evolution, and biology of the MUC4 mucin. FASEB J. 22, 966-981 (2008).
39. Workman HC, Sweeney C, Carraway KL 3rd: The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res. 69(7), 2845-2852. ■ Multiple effects of Muc4 on apoptosis.
40. Hu YP, Haq B, Carraway KL, Savaraj N, Lampidis TJ: Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochem. Pharmacol. 65, 1419-1425 (2003).
41. Zhu X, Price-Schiavi SA, Carraway KL: Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/ rat Muc4 in mammary epithelial cells. Oncogene 19, 4354-4361 (2000).
42. Perez A, Barco R, Fernandez I, Price-Schiavi SA, Carraway KL: PEA3 transactivates the Muc4/sialomucin complex promoter in mammary epithelial and tumor cells. J. Biol. Chem. 278, 36942-36952 (2003).
43. Price-Schiavi SA, Perez A, Barco R, Carraway KL: Cloning and characterization of the 5′ flanking region of the sialomucin complex/rat Muc4 gene: promoter activity in cultured cells. Biochem J. 349, 641-649 (2000).
44. Fauquette V, Perrais M, Cerulis S et al.: The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells. Biochem J. 386, 35-45 (2005).
45. Shepherd TG, Kockeritz L, Szrajber MR, Muller WJ, Hassell JA: The pea3 subfamily ets genes are required for HER2/Neumediated mammary oncogenesis. Curr. Biol. 11, 1739-1748 (2001).
46. Perrais M, Pigny P, Copin MC, Aubert JP, Van Seuningen I: Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/ extracellular signal-regulated kinase cascade and Sp1. J. Biol. Chem. 277, 32258-32267 (2002).
47. Van Seuningen I, Jonckheere N: The membrane-bound mucins: how large O-glycoproteins play key roles in epithelial cancers and hold promise as biological tools for gene-based and immunotherapies. Crit. Rev. Oncog. 14, 177-196 (2008).
48. Jonckheere N, Van Seuningen I: The ever-growing family of membrane-bound mucins. In: The Epithelial mucins: Structure-function. Roles in cancer and inflammatory diseases. Van Seuningen I (Ed.), Research Signpost, Kerala, India, 17-38 (2008).
49. Perrais M, Pigny P, Ducourouble MP et al.: Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. J. Biol. Chem. 276, 30923-30933 (2001). ■ Mechanisms of transcriptional regulation of MUC4.
50. Moniaux N, Andrianifahanana M, Brand RE, Batra SK: Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br. J. Cancer 91, 1633-1638 (2004).
51. Jonckheere N, Perrais M, Mariette C et al.: A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-b in pancreatic carcinogenesis. Oncogene 23, 5729-5738 (2004).
52. Andrianifahanana M, Agrawal A, Singh AP et al.: Synergistic induction of the MUC4 mucin gene by interferon-γ and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways. Oncogene 24, 6143-6154.
53. Damera G, Xia B, Ancha HR, Sachdev GP: IL-9 modulated MUC4 gene and glycoprotein expression in airway epithelial cells. Biosci. Rep. 26, 55-67 (2006).
54. Vincent A, Ducourouble MP, Van Seuningen I: Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases. FASEB J. 22, 3035-3045 (2008).
55. Yamada N, Nishida Y, Tsutsumida H et al.: Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Br. J. Cancer 100, 344-351 (2009).
56. van Seuningen I, Vincent A: Mucins: a new family of epigenetic biomarkers in epithelial cancers. Expert Opin. Med. Diag. (2009) (In press).
57. Fischer BM, Cuellar JG, Diehl ML et al.: Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L671-L679 (2003).
58. Fischer BM, Voynow JA: Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am. J. Respir. Cell. Mol. Biol. 26, 447-452 (2002).
59. Price-Schiavi SA, Carraway CA, Fregien N, Carraway KL: Post-transcriptional regulation of a milk membrane protein, the sialomucin complex (Ascites sialoglycoprotein (ASGP)-1/ ASGP-2, rat muc4), by transforming growth factor β. J. Biol. Chem. 273, 35228-35237 (1998).
60. Price-Schiavi SA, Zhu X, Aquinin R, Carraway KL: Sialomucin complex (rat Muc4) is regulated by transforming growth factor β in mammary gland by a novel post-translational mechanism. J. Biol. Chem. 275, 17800-17807 (2000). ■ Post-translational regulation of Muc4 in rat mammary cells by TGFβ.
61. Soto P, Price-Schiavi SA, Carraway KL: SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-β and interferon-γ pathways in rat mammary epithelial cells. J. Biol. Chem. 278, 20338-20344 (2003).
62. Lomako WM, Lomako J, Soto P, Carraway CA, Carraway KL: TGFβ regulation of membrane mucin Muc4 via proteosome degradation. J. Cell Biochem. 107, 797-802 (2009).
63. Price-Schiavi SA, Meller D, Jing X, Merritt J, Carvajal ME, Tseng SC, Carraway KL: Sialomucin complex at the rat ocular surface: a new model for ocular surface protection. Biochem J. 335, 457-463 (1998).
64. Idris N, Carraway KL: Regulation of sialomucin complex/Muc4 expression in rat uterine luminal epithelial cells by transforming growth factor-β: implications for blastocyst implantation. J. Cell Physiol. 185, 310-316 (2000).
65. Aubert S, Van Seuningen I, Leroy X: Mucins in the uro-genital tract. Potential for therapeutic approaches using mucins. In: The Epithelial mucins: Structure-function. Roles in cancer and inflammatory diseases. Van Seuningen I (Ed.), Research Signpost, Kerala, India, 249-272 (2008).
66. Rakha EA, Boyce RW, Abd El-Rehim D et al.: Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod. Pathol. 18, 1295-1304 (2005).
67. Llinares K, Escande F, Aubert S et al.: Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Mod. Pathol. 17, 150-157 (2004).
68. Hanaoka J, Kontani K, Sawai S et al.: Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity. Cancer 92, 2148-2157 (2001).
69. Kwon KY, Ro JY, Singhal N et al.: MUC4 expression in nonsmall cell lung carcinomas: relationship to tumor histology and patient survival. Arch. Pathol. Lab. Med. 131, 593-598 (2007).
70. Tsutsumida H, Goto M, Kitajima S et al.: MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 55, 195-203 (2007).
71. Saitou M, Goto M, Horinouchi M et al.: MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J. Clin. Pathol. 58, 845-852 (2005).
72. Swartz MJ, Batra SK, Varshney GC et al.: MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol. 117, 791-796 (2002).
73. Tamada S, Shibahara H, Higashi M et al.: MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin. Cancer Res. 12, 4257-4264 (2006).
74. Shibahara H, Tamada S, Higashi M et al.: MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39, 220-229 (2004).
75. Zhang S, Zhang HS, Cordon-Cardo C, Ragupathi G, Livingston PO: Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens. Clin. Cancer Res. 4, 2669-2676 (1998).
76. Chauhan SC, Singh AP, Ruiz F et al.: Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod. Pathol. 19, 1386-1394 (2006).
77. Bhattacharyya SN, Dubick MA, Yantis LD et al.: In vivo effect of wood smoke on the expression of two mucin genes in rat airways. Inflammation 28, 67-76 (2004).
78. Liévin-Le Moal V, Huet G, Aubert JP et al.: Activation of mucin exocytosis and upregulation of MUC genes in polarized human intestinal mucin-secreting cells by the thiol-activated exotoxin listeriolysin O. Cell Microbiol. 4, 515-529 (2002).
79. Damera G, Xia B, Sachdev GP: IL-4 induced MUC4 enhancement in respiratory epithelial cells in vitro is mediated through JAK-3 selective signaling. Respir. Res. 7, 39 (2006).
80. Mejías-Luque R, Peiró S, Vincent A, Van Seuningen I, de Bolós C: IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines. Biochim. Biophys. Acta 1783, 1728-1736 (2008).
81. Choudhury A, Singh RK, Moniaux N, El-Metwally TH, Aubert JP, Batra SK: Retinoic acid-dependent transforming growth factor-β 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-a signaling pathway. J. Biol. Chem. 275, 33929-33936 (2000).
82. Andrianifahanana M, Agrawal A, Singh AP et al.: Synergistic induction of the MUC4 mucin gene by interferon-γ and retinoic acid in human pancreatic tumour cells involves a reprogramming of signaling pathways. Oncogene 24, 6143-6154 (2005).
83. Singh AP, Chauhan SC, Andrianifahanana M et al.: MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene 26, 30-41 (2007).
84. Mariette C, Perrais M, Leteurtre E et al.: Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway. Biochem J. 377, 701-708 (2004).
85. Piessen G, Jonckheere N, Vincent A et al.: Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1α. Biochem J. 402, 81-91 (2007).
86. Jonckheere N, Vincent A, Perrais M et al.: The human mucin MUC4 is transcriptionally regulated by caudal-related homeobox, hepatocyte nuclear factors, forkhead box A, and GATA endodermal transcription factors in epithelial cancer cells. J. Biol. Chem. 282, 22638-22650 (2007).